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Taking into account he perimembrane localization of caldesmon [(1986) Nature 319,681 and its ability to participate in the regulation of receptor 
clusterization [(1989) J. Biol. Chem. 264, 4961, we studied the interaction of duck gizzard caldesmon with soybean phospholipids (azolectin). By 
using four independent methods, i.e. light scattering, gel-electrophoresis, gel-filtration and ultracentrifugation, we showed a Ca-independent com- 
plex formation between caldesmon and azolectin. Interacting with caldesmon, calmodulin is shown to dissociate the caldesmon-azolectin complex. 
It is supposed that the caldesmon-phospholipid interaction may affect caldesmon phosphorylation by Ca-phospholipid-dependent protein kinase. 
This effect may be important for various cell motility processes. 
Caldesmon; Phospholipid; Phosphorylation 
1. INTRODUCTION 
Caldesmon is a multifunctional actin- and calmo- 
dulin-binding protein [ 1,2]. Caldesmon is supposed to 
be involved in the regulation of smooth muscle con- 
traction [3]. Recently published data indicate that 
caldesmon plays a role in chromaffin granule secretion 
[4] as well as in the capping of receptors on the surface 
of lymphoma T cells [2,5]. In certain cells caldesmon is 
located close to the surface membrane [4]. Moreover, 
many actin-binding proteins (profilin, gelsolin, 
myosin-1) are able to interact with phospholipids [6-81. 
These results prompted the present investigation into 
the interaction of duck gizzard caldesmon with a mix- 
ture of soybean phospholipids (azolectin). 
2. MATERIALS AND METHODS 
Duck gizzard caldesmon and bovine brain calmodulin were 
isolated according to earlier described methods [9,10]. Chymotryptic 
cleavage of caldesmon was performed as described by Fujii et al. [ 111. 
Ca-phospholipid-dependent protein kinase (protein kinase C) was 
isolated from rat brain [12]. The phospholipid-independent form of 
the enzyme was obtained by two cycles of freezing and thawing of the 
partially purified protein kinase C. The chymotryptic peptide map in- 
dicates that both enzymes phosphorylate the same sites in caldesmon. 
Phosphorylation of caldesmon by protein kinase C and the phos- 
pholipid-independent form of the enzyme was performed under 
earlier described conditions. Phospholipid suspension (2-10 mg/ml) 
was obtained after 3-fold sonication (30 s) of azolectin (Serva) in 20 
mM Tris-HCI, pH 7.5, 0.1 mM EDTA. 
In experiments with light scattering, the azolectin suspension 
(lo-20 mg/ml) in 50 mM imidazoles-HCl, pH 7.0, and 0.1 mM CaC12 
was titrated with caldesmon. Light scattering was measured in a 1 ml 
Correspondence address: N.B. Gusev, Department of Biochemistry, 
School of Biology, Moscow State University, Moscow 119899, USSR 
134 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 
cell at 25°C on a Hitachi F-3000 fluorometer setting the wavelength 
of emission and excitation at 340 nm. 
The method of electrophoresis under non-denaturating conditions 
[13] was used for investigation of the caldesmon/azolectin i terac- 
tion. Caldesmon (0.1-0.3 mg/ml) was mixed with the azolectin 
suspension (O-O.2 mg/ml) in the presence of 2 mM EGTA or 0.1 mM 
Car& and after lo-15 min incubation at room temperature was load- 
ed on the gel. 
Gel-filtration was performed at 4°C on a Sepharose 4B column 
(450x 16 mm) equilibrated with buffer A (10 mM Tris-HCI, pH 7.2, 
containing 100 mM NaCl, 0.1 mM NaNs, 3 mM dithiothreitol, 0.1 
mM phenylmethylsulfonylfluoride, 1 mM benzamidine, I pg/ml 
leupeptin and either 2 mM EGTA or 0.1 mM NaClz). Caldesmon 
(0.6-0.8 mg/ml) was mixed with azolectin (O-6 mg/ml) and incubated 
in buffer A for 15-30 min at room temperature. The sample (0.5-1.0 
ml) was loaded on the column, and after completion of experiment 
aliquots of each fraction were monitored for protein content by the 
Spector method [14]. For experiments performed by ultracentrifuga- 
tion intact caldesmon or a mixture of chymotryptic peptides of 
caldesmon (0.1-0.5 mg/ml) in 20 mM Tris-HCI pH 7.5, 0. I M NaCl 
in the presence of 2 mM EGTA or 0.4 mM CaClz were mixed with 
azolectin (O-O.9 mg/ml), incubated for 15-30 min at room tem- 
perature and subjected to centrifugation at 105 000 x g (1 h, 4’C). Ali- 
quots of the pellet and supernatant were analyzed by electrophoresis 
in polyacrylamide gel in the presence of sodium dodecyl sulphate [151. 
To prevent he non-specific adsorption in several experiments bovine 
serum albumin (0.3-0.6 mg/ml) was added to the incubation mixture. 
3. RESULTS 
Titration of azolectin suspension by caldesmon leads 
to an increase in light scattering (Fig. 1). The titration 
curve was hyperbolic and the saturation was observed 
at the caldesmon : azolectin weight ratio equal to 5. 
Taking the average molecular weight of the phospho- 
lipid equal to 750 kDa and that of caldesmon to 87 kDa 
[16,17], one can estimate that one molecule of 
caldesmon interacts with 20-25 molecules of phospho- 
lipid. Thus, experiments on light scattering indicate that 
caldesmon can interact with azolectin. 
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Fig. 1. Caldesmon induced increase in the light scattering of azolectin 
suspension. The incubation mixture (50 mM imidazole/HCI, pH 7.0, 
0.1 mM CaClz) did not contain azolectin (curve 1) or contained 20 
pg/ml of azolectin (curve 2). 
This conclusion was checked by the method of gel- 
electrophoresis. Caldesmon has rather a low elec- 
trophoretic mobility at alkaline pH values in the 
absence of denaturating agents (Fig. 2). Addition of 
small quantities of azolectin results in the formation of 
a new band having a lower electrophoretic mobility 
than isolated caldesmon. In the presence of greater 
quantities of azolectin the band of isolated caldesmon 
completely disappears and the protein does not enter 
the gel (Fig. 2). These data indicate that under the con- 
ditions used caldesmon strongly interacts with azolectin 
and is thus unable to enter the gel. To verify this 
assumption we used the method of gel-filtration. 
Isolated vesicles of azolectin are eluted from the col- 
umn of Sepharose 4B in excluded volume (fractions 
11-13 on Fig. 3). Isolated caldesmon enters the gel and 
is eluted from the column in fractions 21-23 (Fig. 3). 
When the caldesmon/azolectin mixture was loaded on 
the column a part of the protein was eluted in the ex- 
cluded volume. The amount of caldesmon bound to 
azolectin depends on the initial concentration of the 
protein and phospholipid in the sample subjected for 
gel-filtration (cf. Fig. 3A and B). These experiments 
were performed in the presence of 0.1 mM CaCI2 and 2 
mM EGTA. The formation of caldesmon-phospholipid 
complex was observed both in the presence and absence 
of Ca2+. 
The method of ultracentrifugation in addition to the 
three previously described approaches (light scattering, 
gel-electrophoresis and gel-filtration) was used to ob- 
tain further data on the caldesmon/phospholipid in- 
teraction. In these experiments rather low 
concentrations of phospholipid and caldesmon were us- 
ed. Even at caldesmon concentration of 0.3 mg/ml and 
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Fig. 2. Effect of azolectin on the electrophoretic mobility of 
caldesmon. The concentration of caldesmon in the sample loaded on 
the gel was 0.1 mg/ml; that of azolectin was equal to 0 (slot 1). 30 (slot 
2), 60 (slot 3), 100 (slot 4), 150 (slot 5) and 2OOpg/ml (slot 6), respec- 
tively. 
that of azolectin 0.8 mg/ml, about 20% of the protein 
was bound to azolectin and sedimented upon ultracen- 
trifugation. Worth noting is that addition of bovine 
serum albumin (up to 0.3-0.6 mg/mi) to the incubation 
mixture did not prevent the interaction of caldesmon 
with phospholipids. When the mixture of chymotryptic 
peptides of caldesmon and azolectin was subjected to 
ultracentrifugation, the pellet formed thereby was 
enriched in the peptides with M, of 40 and 20000, 
whereas the supernatant contained higher quantities of 
peptides with M, of 25 000-27 000 and 60 000. Taking 
into account the literature data [ 12,17,18], we may sup- 
pose that the phospholipid-binding site of caldesmon is 
located in the C-terminal chymotryptic peptide of 
caldesmon, i.e. close to the sites involved in the 
caldesmon interaction with actin and calmodulin. 
hacticin number 
Fig. 3. Gel-filtration of azolectin/caldesmon mixture on a Sepharose 
4B column. The sample (final vol. 0.96 ml) loaded on the column con- 
tained caldesmon (1.3 mg/ml) and azolectin - 1.52 mg/ml in A and 
6.34 mg/ml in B. Ordinate: absorbance at 595 nm as determined after 
protein staining with Coomassie G-250. Arrows 1 and 2 indicate the 
position of separately chromatographed azolectin and caldesmon, 
respectively, whereas the profiles were obtained with the correspon- 
ding mixtures. 
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4. DISCUSSION 
Using four different methods - light scattering, gel- 
filtration, gel-electrophoresis and ultracentrifugation - 
we succeeded in showing that smooth muscle caldesmon 
interacts with soybean phospholipids (azolectin). This 
fact seems to be important from many viewpoints. As 
was mentioned earlier, caldesmon may be located close 
to the membrane [4] and be involved in the regulation 
of exocytosis and receptor capping [2,5]. Caldesmon 
can regulate these processes because it is able to interact 
with actin and myosin 11,191 as well as with phospho- 
lipids (this publication). It is well known that cyto- 
skeletal proteins preferentially interact with acidic 
phospholipids (phosphatidylserine and phosphoinosi- 
tides) [6-81. The mixture of phospholipids used in the 
present study (azolectin) alongside with phosphatidyl- 
choline and phosphatidylethanolamine contains about 
15% of phosphatidylinositols [ZO]. We may suppose 
that caldesmon primarily interacts with these acidic 
phospholipids. There are several facts supporting this 
assumption. Our preliminary data obtained through the 
method of gel-electrophoresis ndicate that caldesmon 
interacts with phosphatidylserine more readily than 
with phosphatidylcholine. Moreover, ultracentrifuga- 
tion data indicate that the C-terminal chymotryptic 
peptide of caldesmon interacts with azolectin. This pep- 
tide is enriched by positively charged amino acids and 
contains a fragment including residues 608-624 which 
seems to be able to form an amphiphilic a-helix 121,221. 
It is supposed that this site is involved in the caldesmon/ 
calmodulin interaction. At the same time it is obvious 
that the fragment containing a number of hydrophobic 
and positively charged residues may form a tight com- 
plex with phospholipids. For example, the fragment of 
gelsolin with these properties does interact with phos- 
pholipids 171. If our assumption is correct, one may ex- 
pect that calmodulin will compete with phospholipids 
for the interaction with caldesmon. Indeed, in ex- 
periments with gel electrophoresis we found that in the 
presence of Ca2’ calmodulin brings about the dissocia- 
tion of the caldesmon-phospholipid complex. Under 
these conditions caldesmon interacts with calmodulin 
and penetrates the gel. 
Ca-phospholipid-dependent protein kinase is able to 
phosphorylate caldesmon [ 12,23-251. The sites phos- 
phorylated by this enzyme are located in the C-terminal 
chymotryptic peptide of caldesmon [12,24,26]. Since 
both the caldesmon and protein kinase C are able to in- 
teract with the membrane these proteins may be located 
in the same compartment. This circumstance increases 
the probability of caldesmon phosphorylation by pro- 
tein kinase C. Many well known in vitro substrates of 
protein kinase C strongly interact with phospholipids 
which affect the structure of this protein [27]. One may 
expect that phosphorylation will influence the interac- 
tion of proteins with phospholipids. Indeed our pre- 
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liminary data indicate that phosphorylation of 
caldesmon (up to 0.9 mol of phosphate per mol of pro- 
tein) by a phospholipid-independent form of protein 
kinase C results in a prominent decrease in the strength 
of the azolectin/caldesmon interaction. This is an in- 
direct indication that the site of interaction with the 
phospholipid is located in the C-terminal fragment of 
caldesmon, i.e. close to the sites involved in the contact 
with actin and calmodulin. 
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